029HO18858 ENTITY

Print/PDF
Registration Name DENOVO 8084 ENTITY-ET
Registration Number HO840003141494670
Primary NAAB Code 029HO18858
Secondary Code(s) 629HO18858
Status Inactive
Controller Name ABS Global (29)
Date of Birth 9/24/2017
aAa 165
DMS -
GFI 12.5%
Genetic Codes * TY TD TL TR TV TC TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T
Sire TRIPLECROWN JW MATTERS-ET
MGS EDG RUBICON-ET
Beta Casein A1A2
Kappa Casein AE
Beta Lactoglobulin BB
INDEXES
NM$ 559, 95% R CM$ 572
NM Percentile 55% FM$ 530
GTPI 2943 GM$ 528
PRODUCTION TRAITS
10001 Dtrs 1030 herds 38 % US 99% R
Milk 739 Fat, % 81 , +0.19%
SCS 3, 99% R Protein, % 31 , +0.03%
Feed Saved -68 , 73% R Milking Speed 6.5 , 96% R
Health & Fertility
Productive Life 1.1      99% R Mastitis -0.4      98% R
Heifer Livability 0.6       91% R Metritis 0.3      97% R
Livability 1.7      96% R D. Abom 0.4      98% R
DPR -0.8      99% R Ketosis -1.4      95% R
FSC 1.5      99% R R. Placenta -0.6      97% R
HCR -2.5      98% R Milk Fever -0.1      92% R
CCR -0.3      99% R
SCR -        -
DIA -3.7      81% R
RSP 2.6      89% R
Calving Traits
Sire CE 1.3      98% R 5693 Obs
Daughter CE 1.6      97% R 1392 Obs, 3736 Dtrs
Sire SB 3.5      96% R 6392 Obs
Daughter SB 4.3      96% R 1017 Obs, Dtrs
Gestation Length 0.0      99% R 235 Obs, 4180 Dtrs
Early First Calving 0.9      99% R 190 Obs, 3314 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
2991 Dtrs 380 herds 98% R
PTA Type -0.03 UDC -0.18
HCC 0.70 BWC 0.06
FLC 0.60
Linear Traits
Stature -0.04
Short
Strength -0.08
Weak
Body Depth -0.53
Shallow
Dairy Form -0.20
Closed
Rump Angle 0.11
Sloped
Thurl Width 0.44
Sloped
Rear Legs-Side View 0.44
Wide
Rear Legs-Rear View 0.98
Straight
Foot Angle -0.01
Low
Feet & Legs Score 0.47
High
F.U. Attachment 0.54
Curved
Rear Udder Height -0.19
Low
Rear Udder Width -0.42
Narrow
Udder Cleft 0.17
Strong
Udder Depth 0.98
Straight
Front Teat Placement 0.62
Close
Rear Teat Placement 0.97
Close
Teat Length -1.07
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO